PVR and neoplasm: CD155 is expressed at low levels in many normal tissues, but the upregulation of CD155 is reported in many tumor cells, such as melanoma, pancreatic cancer, lung adenocarcinoma, colon cancer, and glioblastoma, and it is involved in tumor development and invasion and is correlated with poor clinical outcomes [198].